See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.75▲ 0.14%Gold spot3,994▼ 0.75%WTI103.27▲ 3.82%
← V2TX34 page
XStocksXray
Market X-Ray report · 23 October 2026

VTEX (V2TX34)

Sao Paulo Exchange · Brazil · prices in BRL · close of 23 Oct 2026

Key indicators

Last closeBRL 21.75
52-week range14.26 – 24.54
Return, 1 month / 3 months+17.3% / +17.6%
Return, 1 year / 3 years−9.9% / –
TrendUptrend
RSI (14)61
Volatility (1 year)89.8%
Worst drawdown (1 year)-41.8%
Average daily value traded0.24M BRL
Dividend yield–

Market X-Ray price-based

48/ 100 · High confidence · ahead of 45% of stocks on this exchange
Trend62
Momentum54
Stability (higher is calmer)17
Liquidity66
Income–

Five-year price chart navy: price · brown: 200-day average

12.3421.3130.2939.2648.232023-102024-072025-042026-012026-10

About the company

VTEX is a software company that provides a cloud commerce platform for large brands and retailers. Its services help businesses run online stores, marketplaces and order management, and connect with customers across digital channels. The company is based in Brazil and works with enterprise clients in several countries, offering tools for catalog management, checkout, fulfillment and integration with other business systems. Its customers are mainly established consumer brands and retail groups that need a single platform to manage their commerce operations.

VTEX is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code V2TX34, with its price quoted in Brazilian reais (BRL). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

VTEX (V2TX34) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 21.75 on 23 October 2026.

Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 804 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 9.9% and over the last three months it rose 17.6%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
VTEX (V2TX34)

The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange

Lens and metricValueScoreReading
Trend62 · FairMixed trend against its averages.
Above 200-day average12.8%
From 52-week high-11.3%
Momentum54 · FairTypical recent returns for this exchange.
3-month return17.6%
6-month return10.4%
12-month return, skipping the last month-23.2%
Stability (higher is calmer)17 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)89.8%
Worst drawdown, 1 year (smaller is calmer)-41.8%
Liquidity66 · FairModerate trading activity.
Average daily value traded0.24M BRL
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week+3.2%
1 month+17.3%
3 months+17.6%
6 months+10.4%
1 year−9.9%
3 years–
5 years–

Signals

50-day / 200-day average19.23 / 19.28
Golden / death cross (60 days)Death, 5 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.73

Technical summary

DailyStrongly bullish12 bullish · 4 neutral · 0 bearish
WeeklyBullish7 bullish · 1 neutral · 2 bearish
MonthlyBearish2 bullish · 1 neutral · 3 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 25 Oct 2026